Proposal for a Standardized PSA Doubling-time Calculation | Anticancer Research
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
PDF) Comparison of Different Machine Learning Models in Prediction of Postirradiation Recurrence in Prostate Carcinoma Patients
Prostate cancer screening—when to start and how to screen? - Kohestani - Translational Andrology and Urology
Mortality results from the Göteborg randomised population-based prostate-cancer screening trial - The Lancet Oncology
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the placebo arm of the SPCG-6 study - Annals of Oncology
Prostate Cancer Nomograms: PSA Doubling Time | Memorial Sloan Kettering Cancer Center
The PSA-doubling time in patients with different rate of prostate... | Download Table
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Long-Term Outcomes After High-Dose Postprostatectomy Salvage Radiation Treatment - International Journal of Radiation Oncology, Biology, Physics
Prostatic Specific Antigen for Prostate Cancer Detection
Clinical significance of the prostate-specific antigen doubling time prior to and following radical prostatectomy to predict the outcome of prostate cancer
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Prostate-specific antigen doubling time as a prognostic marker in prostate cancer | Nature Reviews Urology
Association between PSA kinetics and cancer-specific mortality in patients with localised prostate cancer: analysis of the place
PSA Doubling Time Calculator
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC) | Journal for ImmunoTherapy of Cancer
Implications of Prostate-Specific Antigen Doubling Time as Indicator of Failure after Surgery or Radiation Therapy for Prostate Cancer - European Urology
Month 134 – PSA Results | Dan's Journey through Prostate Cancer
Day 3,508 – PSA Results | Dan's Journey through Prostate Cancer
Summary of PSA Doubling Time and Velocity Definitions | Download Table
